Mirion Technologies, Inc. Class A Common Stock (MIR)

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs, reignited trade policy uncertainty. The move came swiftly after the Supreme Court ruled the previous week that the president could not use the International Emergency Economic Powers Act (IEEPA) for such duties, a decision that had initially sent markets higher. However, the administration invoked a different authority, the Trade Act of 1974, to impose a 15% global tariff for up to 150 days. The rapid reimposition of trade barriers creates significant uncertainty for companies across multiple sectors that depend on international supply chains and global trade. Investors are now weighing the potential impact of these new duties on corporate earnings and broader economic activity.

Mirion’s fourth-quarter results were met with a negative market reaction, reflecting missed revenue and non-GAAP EPS expectations. Management attributed the softer top-line to challenging comparisons in its labs and research and RTQA (Radiation Therapy Quality Assurance) segments, as well as delays in government-related orders due to a prolonged shutdown. CEO Thomas Logan explained that strong order growth in nuclear power and nuclear medicine helped offset these headwinds, with Logan noting, “We booked record orders in 2025 totaling more than $1 billion, largely driven by the nuclear power market.”

Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Citi’s 2026 Global Industrial Tech and Mobility Conference. The presentation will begin at 2:40 PM ET on Wednesday, February 18, 2026.

Radiation safety company Mirion (NYSE:MIR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 9.1% year on year to $277.4 million. Its non-GAAP profit of $0.15 per share was 7.8% below analysts’ consensus estimates.

Mirion (MIR) Q4 2025 Earnings Call Transcript

Mirion (NYSE: MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting the company’s continued focus on safety, innovation, operational excellence and long-term growth.

Radiation safety company Mirion (NYSE:MIR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 9.1% year on year to $277.4 million. Its non-GAAP profit of $0.15 per share was 7.8% below analysts’ consensus estimates.

Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2025.

Radiation safety company Mirion (NYSE:MIR) will be reporting earnings this Tuesday after market hours. Here’s what you need to know.

Lindsay Corporation delivers irrigation and infrastructure solutions to global agriculture and transportation markets.

Core Scientific provides blockchain infrastructure and digital asset mining for institutional and enterprise clients in North America.

AZZ Inc. delivers metal coatings and electrical infrastructure solutions to industrial and utility clients worldwide.

Ardent Health operates a national network of hospitals and clinics, delivering acute care and specialty medical services across the U.S.

A number of stocks fell in the afternoon session after sentiment weakened following a surprisingly weak private payrolls report from ADP. 

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.

Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2025 after market close on Tuesday, February 10, 2026. Following the news release, the company will host a conference call the next day, Wednesday, February 11, 2026, at 11:00 am ET to discuss the results.

Business services providers play a critical role for enterprises, assisting them with everything from new hardware integrations to consulting and marketing. Furthermore, the demand for their offerings is rising as more clients outsource non-core functions, a trend that has enabled the industry to return 8.7% over the past six months, almost identical to the S&P 500.

A number of stocks traded in opposite directions in the afternoon session after geopolitical tensions between the United States and the European Union escalated, sparking fears of a renewed trade war. 

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the specialized technology stocks, including Mirion (NYSE:MIR) and its peers.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

A number of stocks fell in the afternoon session after investors rotated out of AI-linked high-flyers following underwhelming earnings updates from Oracle and Broadcom as the core thesis shifted from "growth at any cost" to "prove the returns."